Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (703)
  • News item (337)
  • Subject (111)
  • Blog post (45)
  • Single page (5)
  • Activity (2)

Publication date

Selecting an option will change the focus to the start of the list.
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (17)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • April 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (3)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (15)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (185)
  • COVID-19 (96)
  • International projects (64)
  • Nanotechnology and advanced materials (53)
  • Food safety (22)
  • Circular economy (20)
  • RIVM (20)
  • Soil and water (20)
  • Flu and flu vaccine (19)
  • Tobacco (17)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (17)
  • Alternatives to animal testing (15)
  • Antimicrobial resistance (15)
  • Behavioural science (15)
  • Consumer exposure to chemical substances (15)
  • Heat (15)
  • National Immunisation Programme (14)
  • Food and Nutrition (13)
  • Rubber granulate (13)
  • Sexually transmitted infections (STIs) (13)
  • Health research for COVID-19 (12)
  • Immunisation and vaccination (11)
  • Incidents and disasters (11)
  • Infectious Disease Control (11)
  • Mpox (11)
  • Occupational Safety (11)
  • Plastics (11)
  • Cervical cancer screening programme (10)
  • ConsExpo (10)
  • One Health (10)
  • PFAS (10)
  • Tick bites (10)
  • Dutch National Food Consumption Survey (9)
  • Medical devices (9)
  • Public Health Foresight (9)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (9)
  • Zoonotic diseases (9)
  • Mental Health (8)
  • Tuberculosis (8)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (8)
  • WHO Collaborating Centre on Chemical Food Safety (8)
  • Pneumococci (7)
  • Respiratory infections (7)
  • Sustainability (7)
  • West Nile fever (7)
  • Mosquitos (6)
  • National Security (6)
  • Population screening programs in the Caribbean Netherlands (6)
  • Climate change and Health (5)
  • Food contact materials (5)
  • Healthy living environment (5)
  • Measles (5)
  • Nitrogen (5)
  • Respiratory syncytial virus (RSV) (5)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (5)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Breast Cancer Screening Programme (4)
  • Dengue (4)
  • Endocrine disrupting chemicals (4)
  • Gonorrhoea (4)
  • HPV (4)
  • PIENTER Corona Study (4)
  • Population screening programmes (4)
  • Public Health Monitors (4)
  • Sustainable Development Goals (4)
  • Whooping cough (4)
  • Bird flu (avian influenza) (3)
  • Chromium (VI) and CARC (3)
  • Climate change (3)
  • DNA and public health (3)
  • Electromagnetic Fields (3)
  • Group A Strep infections (3)
  • Life Cycle Assessment (LCA) (3)
  • Lyme disease (3)
  • Malaria (3)
  • Meningococcal disease (3)
  • Physical Activity (3)
  • Tick-borne encephalitis (3)
  • UV index (3)
  • Wastewater research (3)
  • WHO Collaborating Centre for Immunotoxicology and Allergic Hypersensitivity; discontinued (3)
  • WHO Collaborating Centre for Nutrition (3)
  • Chikungunya (2)
  • Coronaviruses (2)
  • Ebola (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Legionella (Legionellosis) (2)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (2)
  • Livestock farming and health (2)
  • PFAS (2)
  • Probit functions (2)
  • Radiation and radioactivity (2)
  • Rubber tiles (2)
  • Salmonella (2)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (2)
  • Zika Virus (2)
  • Arboviruses (1)
  • Bestrijdingsmiddelen (1)
  • Chickenpox (1)
  • Contact (1)
  • Corona (1)
  • Digitale zorg (1)
  • Doetinchem Cohort Study (1)
  • Dutch Food Composition Database (NEVO) (1)
  • Environmental and industrial safety (1)
  • Exploratory study into environmental pollution and health on Bonaire (1)
  • Fipronil in eggs (1)
  • Global Health Security (1)
  • Health promotion (1)
  • Healthy City (1)
  • Heel prick (1)
  • Hepatitis A (1)
  • Hepatitis B (1)
  • HPV - Humaan Papillomavirus (1)
  • Lifestyle interventions (1)
  • Marburg virus disease (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • MERS (1)
  • NoroNet (1)
  • One Health (1)
  • Perinatal screening (1)
  • Pharmaceuticals in the environment (1)
  • Polio (1)
  • Rotavirus (1)
  • Scabies (1)
  • Shigellosis (1)
  • Shingles (1)
  • Synthetic biology (1)
  • WHO Collaborating Centre for Smallpox Vaccine (1)
  • WHO Collaborating Centre for the Family of International Classifications (FIC) (1)
  • WHO Collaborating Centre on Life Course and Health (1)

1236 search results

You searched for these word(s): risk assessment
  • VECTOR study – Vaccine effectiveness against COVID-19 related hospital admissions in risk groups

    https://www.rivm.nl/en/vector

    … vaccinated and still get COVID-19 generally have a lower risk of a severe course of the disease, and therefore have a lower risk of being admitted to hospital due to COVID-19.  The … also possible to look at vaccine effectiveness in specific risk groups. The study also examines how long protection …

    Publication date: 11-22-2021
  • GRACIOUS

    https://www.rivm.nl/en/international-projects/gracious

    … number of cases. Grouping and read-across are approaches in risk assessment to fill in data gaps for a specific material by … for which adequate information is available to allow for risk assessment, for example, needed to comply with … and classificatiOn framework for regUlatory risk assessment of manufactured nanomaterials and Safer …

    Publication date: 05-23-2018
  • Changes to the human environment: urgent focus on infectious diseases needed

    https://www.rivm.nl/en/news/changes-to-human-environment-urgent-focus-on-infectious-diseases-needed

    … to the living environment can unintentionally increase the risk of spreading pathogens. This can be prevented through … with which municipalities, for example, can assess the risk of an infectious disease. In addition, platforms must … Although a green environment is essential, people are at risk of being bitten by ticks, for example, or of falling …

    Publication date: 10-20-2022
  • OECD proposes tiered approach for testing bioaccumulation of nanomaterials

    https://www.rivm.nl/en/weblog/oecd-proposes-tiered-approach-for-testing-bioaccumulation-of-nanomaterials

    … Bioaccumulation assessment of nanomaterials cannot be done using the … Therefore, the current guidance on bioaccumulation assessment is not suitable for nanomaterials. To address … testing is required for regulatory chemical risk assessment, including for nanomaterials. When chemicals …

    Publication date: 04-30-2024
  • Prof. dr. M. (Mirjam) Luijten

    https://www.rivm.nl/en/about-rivm/knowledge-and-expertise/experts-and-expertise/prof-dr-m-mirjam-luijten

    … is senior researcher in the field of next-generation risk assessment, an innovative approach for assessing health risks that chemicals may pose to humans. She works as a …   Mirjam is well-versed in next-generation risk assessment. This approach combines a variety of (test) …

    Publication date: 03-10-2026
  • COVID-19 vaccination for risk groups: over-60s, flu vaccine group, care workers and pregnant women

    https://www.rivm.nl/en/news/covid-19-vaccination-for-risk-groups-over-60s-flu-vaccine-group-care-workers-and-pregnant

    … present and may rise again. For people who have a higher risk of serious illness due to COVID-19, the COVID-19 … protection against hospital admission and reduces their risk of death due to COVID-19.  It is not necessary for … on their own or with assistance, but do have an increased risk of serious illness from COVID-19, can contact their …

    Publication date: 09-13-2023
  • Children's exposure to chemical substances

    https://www.rivm.nl/en/consumer-exposure-to-chemical-substances/children-s-exposure

    … Knowledge on the exposure part of the risk assessment is equally important as knowledge on the … endpoints, but this knowledge is scarce.  In exposure assessment, attention for a sensitive subpopulation such as … awareness for the inclusion of children’s exposure in risk assessments, specifically in a product safety …

    Publication date: 02-01-2012
  • Laws and regulations

    https://www.rivm.nl/en/nanotechnology/laws-and-regulations

    … Due to the unique properties of advanced (nano)materials, risk assessment methods sometimes need to be adapted. This also … to the laws and regulations that set requirements for such assessments. RIVM assists the European Commission and Dutch … in the  research and innovation that they support. Risk assessment of advanced (nano)materials The risk …

    Publication date: 07-19-2012
  • First COVID-19 vaccination invitations for children aged 5-11 years in medical risk groups

    https://www.rivm.nl/en/news/first-covid-19-vaccination-invitations-for-children-aged-5-11-years-in-medical-risk-groups

    … invitations for children aged 5-11 years in medical risk groups …

    Publication date: 12-17-2021
  • PROAST

    https://www.rivm.nl/en/proast

    … and the derivation of a Benchmark dose (BMDL) in human risk assessment (or an ECx in ecotoxicological risk assessment). More generally, it can be used for … for deriving a Reference Point (Point of Departure) for risk assessment ( EFSA, 2017). The BMD method pre-defines a …

    Publication date: 03-08-2012
  • RIVM advises against using products containing the herbs Huperzia serrata, Tabernanthe iboga or Ashwagandha

    https://www.rivm.nl/en/news/rivm-advises-against-using-products-containing-herbs-huperzia-serrata-tabernanthe-iboga-or

    … can be harmful to health. RIVM has identified the risks of these herbs and advises consumers, and especially …

    Publication date: 03-08-2024
  • proclaimer nanotool

    https://www.rivm.nl/en/en/consexpo/related-tools/nano-tool/proclaimer

    … It is recommended that experts (nanotoxicology, exposure assessment and risk assessment) are responsible for the evaluation and … of the results of the model is required as a basis for risk assessment.  RIVM is not responsible for the … expert knowledge on consumer exposure assessment and risk assessment.  When used as a starting point for risk …

    Publication date: 10-03-2016
  • EFSA introduces new guidance for evaluating dissolution of nanomaterials in fat

    https://www.rivm.nl/en/weblog/efsa-introduces-new-guidance-for-evaluating-dissolution-of-nanomaterials-in-fat

    … (K OW ) method nanospecific considerations for safety assessments may potentially be waived. However, EFSA also … limitations make it difficult to apply this method to risk assessments of nanoparticles used in applications other than …

    Publication date: 12-19-2024
  • New hold on vaccination with AstraZeneca for people under 60 years

    https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years

    … Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …

    Publication date: 04-02-2021
  • EFSA-RIVM Partnership

    https://www.rivm.nl/en/food-safety/efsa-rivm-partnership

    … Authority (EFSA) is directed to making the  Monte Carlo Risk Assessment ( MCRA) model accessible to all countries and … that pesticides residues do not present an unacceptable risk to humans, hereby also taking into account possible … EFSA-RIVM partnership, aiming to make the Monte Carlo Risk Assessment (MCRA) software scalable for large cumulative …

    Publication date: 12-16-2015
  • Harmful components in products and their emissions

    https://www.rivm.nl/en/tobacco/research-lines/research-lines-product-composition-emissions/harmful-components-in-products-and-their-emissions

    … and their emissions are measured at RIVM to support risk assessments, ongoing research, and regulation. This webpage … in the emissions of e-cigarettes to support health risk assessment and bystander risk assessment and as an indicator … Some VOCs have a comparatively large impact on the health risks of tobacco- and nicotine products. RIVM measures these …

    Publication date: 06-14-2023
  • Centre for Zoonoses and Environmental Microbiology

    https://www.rivm.nl/en/about-rivm/organisation/centre-for-zoonoses-and-environmental-microbiology

    … The centre is responsible for the early warning and risk assessment of the transmission of pathogenic microorganisms … and Consumer Products Safety Authority (NVWA) and RIVM. Risk assessment involves making an estimate of the disease …

    Publication date: 12-16-2013
  • Safety and security (SPR 2019-2022)

    https://www.rivm.nl/en/about-rivm/knowledge-and-expertise/strategic-programme-rivm/2019-2022/safety-and-security

    … to a safe living environment and to protect it against the risks of large-scale and (possibly) socially disruptive … By safety, we usually mean that there are no dangers or risks. Or if they do occur, how governments protect society against the risks and help limit the consequences . …

    Publication date: 08-19-2019
  • Chemicals in food

    https://www.rivm.nl/en/food-safety/chemicals-in-food

    … to chemical food safety by supporting governments with risk assessment, consultancy, methodology development and more. … effects on organs or physiology (toxic effects). The risk of health effects from most chemicals is negligible, … RIVM supports the government by conducting risk assessments, providing policy recommendations and developing …

    Publication date: 12-12-2017
  • Report EFSA-RIVM Symposium

    https://www.rivm.nl/en/food-safety/efsa-rivm-symposium/report-efsa-rivm-symposium

    … reflect on the state of play in research with regard to the risk assessment and toxicity testing of chemical mixtures in … the European Commission are developing a process by which risk assessment of mixtures can be integrated into future …

    Publication date: 06-07-2016

Pagination

  • « First
  • ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon